Cormorant Private Healthcare Fund II, LP, 10% Owner at MoonLake Immunotherapeutics (MLTX), bought 117,678 shares at $59.90 ($7.0M) on 2023-10-05, disclosed to the SEC on 2023-10-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.90 | 58,839 | $3.5M | 50.0% |
| 2 | $59.90 | 58,839 | $3.5M | 50.0% |
| Total | $59.90 avg | 117,678 | $7.0M | 100% |